232
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Factors Associated with Mortality in Critically Ill Patients Diagnosed with Hospital Acquired Infections

, , ORCID Icon, , , ORCID Icon, , , , , , & ORCID Icon show all
Pages 2811-2817 | Published online: 12 Aug 2020

References

  • Ministério da Saúde.. Portaria 2.616, de 12 de maio de 1998, Diretrizes para prevenção e controle das infecções hospitalares. 1998 Available from: https://bvsms.saude.gov.br/bvs/saudelegis/gm/1998/prt2616_12_05_1998.html. Accessed February 4, 2020.
  • Haque M, Sartelli M, McKimm J, Bakar MA. Health care-associated infections an overview. Infect Drug Resist. 2018;11:2321–2333. doi:10.2147/IDR.S17724730532565
  • van Duin D, Paterson DL. Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned. Infect Dis Clin North Am. 2016;30(2):377–390. doi:10.1016/j.idc.2016.02.004
  • Suetens C, Latour K, Kärki T, et al. Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two european point prevalence surveys, 2016 to 2017. Eurosurveillance. 2018;23(46):1–18. doi:10.2807/1560-7917.ES.2018.23.46.1800516
  • da Silva EP, Duarte VDC, Soares MM, et al. Survival analysis of patients with sepsis in Brazil. Rev Soc Bras Med Trop. 2019;52:1–4. doi:10.1590/0037-8682-0121-2018
  • Souza ES, Belei RA, Carrilho CMD, et al. Mortality and risks related to healthcare-associated infection. Texto Context - Enferm. 2015;24(1):220–228. doi:10.1590/0104-07072015002940013
  • Turrini RNT. Infecção hospitalar e mortalidade. Rev Esc Enferm USP. 2002;36(2):177–183. doi:10.1590/S0080-6234200200020001112599742
  • Oliveira AC, Paula AO, Iquiapaza RA, Lacerda ACDS. Infecções relacionadas à assistência em saúde e gravidade clínica em uma unidade de terapia intensiva. Rev Gaúcha Enferm. 2012;33(3):89–96. doi:10.1590/S1983-1447201200030001223405813
  • McAuley AK, Sanfilippo PG, Hewitt AW, et al. Vitreous biomarkers in diabetic retinopathy: A systematic review and meta-analysis. J Diabetes Complications. 2014;28(3):419–425. doi:10.1016/j.jdiacomp.2013.09.01024630762
  • Yilmaz MI, Sonmez A, Saglam M, et al. Ramipril lowers plasma FGF-23 in patients with diabetic nephropathy. Am J Nephrol. 2014;40(3):208–214. doi:10.1159/00036616925324042
  • Maertzdorf J, McEwen G, Weiner J, et al. Concise gene signature for point of care classification of tuberculosis. EMBO Mol Med. 2016;8(2):86–95. doi:10.15252/emmm.20150579026682570
  • Zak DE, Penn-Nicholson A, Scriba TJ, et al. A blood RNA signature for tuberculosis disease risk: a prospective cohort study. Lancet. 2016:387(10035); 2312–2322. doi:10.1016/S0140-6736(15)01316-127017310
  • ECDC. Surveillance of healthcare-associated infections in Europe 2007 [Internet]; 2007 1–134. Available from: ecdc.europa.eu/en/publications/Publications/120215_SUR_HAI_2007.pdf.
  • Singh JA, Yu S, et al. Utilization due to chronic obstructive pulmonary disease and its predictors: a study using the U.S. National Emergency Department Sample (NEDS). Respir Res. 2016:17(1); 1–9. doi:10.1186/s12931-015-0319-y26739476
  • Alp E, Güven M, Yildiz O, Aygen B, Voss A, Doganay M. Incidence, risk factors and mortality of nosocomial pneumonia in intensive care units: A prospective study. Ann Clin Microbiol Antimicrob. 2004;3:1–7. doi:10.1186/1476-0711-3-1714713319
  • Thomsen RW, Kasatpibal N, Riis A, Nørgaard M, Sørensen HT. The impact of pre-existing heart failure on pneumonia prognosis: population-based cohort study. J Gen Intern Med. 2008;23(9):1407–1413. doi:10.1007/s11606-008-0672-318574639
  • Kolpa M, Walaszek M, Gniadek A, Wolak Z, Dobroś W. Incidence, microbiological profile and risk factors of healthcare-associated infections in intensive care units: A 10 year observation in a provincial hospital in southern Poland. Int J Environ Res Public Health. 2018;15(1):1–16. doi:10.3390/ijerph15010112
  • Laupland KB, Kirkpatrick AW, Church DL, Ross T, Gregson DB. Intensive-care-unit-acquired bloodstream infections in a regional critically ill population. J Hosp Infect. 2004;58(2):137–145. doi:10.1016/j.jhin.2004.06.00715474185
  • Avci M, Ozgenc O, Coskuner SA, Olut AI. Hospital acquired infections (HAI) in the elderly: comparison with the younger patients. Arch Gerontol Geriatr. 2012;54(1):247–250doi:10.1016/j.archger.2011.03.01421529974
  • Vrijens F, Hulstaert F, Devriese S, Van De Sande S. Hospital-acquired infections in Belgian acute-care hospitals: an estimation of their global impact on mortality, length of stay and healthcare costs. Epidemiol Infect. 2012;140(1):126–136. doi:10.1017/S095026881100010021320376
  • Hautemanière A, Florentin A, Hartemann P, Hunter PR. Identifying possible deaths associated with nosocomial infection in a hospital by data mining. Am J Infect Control. 2011;39(2):118–122. doi:10.1016/j.ajic.2010.04.21620888670
  • Gusmão MEN. Infecção Hospitalar: Mortalidade, Sobrevida e Fatores Prognósticos No Hospital Universitário Professor Edgard Santos/UFBA. Universidade Federal da Bahia. 2008:153.
  • Laupland KB, Zygun DA, Davies HD, Church DL, Louie TJ, Doig CJ. Incidence and risk factors for acquiring nosocomial urinary tract infection in the critically ill. J Crit Care. 2002;17(1):50–57. doi:10.1053/jcrc.2002.3302912040549
  • Friedman G, Silva E, Vincent J-L. Has the mortality of septic shock changed with time? Crit Care Med. 1998;26(12):2078–2086.9875924
  • Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39(3):309–317.15306996
  • Vincent J, Rello J, Marshall J, et al. The extended prevalence of infection in the ICU study: EPIC II. Crit Care. 2009;49.
  • Richards MJ, Edwards JR, Culver DH, Gaynes RP, Surveillance I. Nosocomial infections in combined medical surgical Intensive Care Units in the United States. Infect Control Hosp Epidemiol. 2010;21(8):510–515. doi:10.1086/501795
  • Cassini A, Högberg LD, Plachouras D, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56–66.30409683
  • Neubeiser A, Bonsignore M, Tafelski S, et al. Mortality attributable to hospital acquired infections with multidrug-resistant bacteria in a large group of German hospitals. J Infect Public Health. 2020;13(2):204–210.31420314
  • Ali S, Birhane M, Bekele S, et al. Healthcare associated infection and its risk factors among patients admitted to a tertiary hospital in Ethiopia: longitudinal study. Antimicrob Resist Infect Control. 2018;7:2. doi:10.1186/s13756-017-0298-529312659
  • Graffunder EM. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother. 2002;49(6):999–1005.12039892